about
The role of dopaminergic and serotonergic systems in neurodevelopmental disorders: a focus on epilepsy and seizure susceptibilityCombining non-pharmacological treatments with pharmacotherapies for neurological disorders: a unique interface of the brain, drug-device, and intellectual property.Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target DrugsDopamine receptors - IUPHAR Review 13Synaptic roles of cyclin-dependent kinase 5 & its implications in epilepsyReduced D2/D3 Receptor Binding of Extrastriatal and Striatal Regions in Temporal Lobe Epilepsy.Progressive Seizure Aggravation in the Repeated 6-Hz Corneal Stimulation Model Is Accompanied by Marked Increase in Hippocampal p-ERK1/2 Immunoreactivity in NeuronsLessons learned from additional research analyses of unsolved clinical exome cases.Dopamine: A Modulator of Circadian Rhythms in the Central Nervous System.Pharmacokinetic/pharmacodynamic considerations for epilepsy - depression comorbidities.NCS-Rapgef2, the Protein Product of the Neuronal Rapgef2 Gene, Is a Specific Activator of D1 Dopamine Receptor-Dependent ERK Phosphorylation in Mouse Brain.Alleviation of Oxidative Damage and Involvement of Nrf2-ARE Pathway in Mesodopaminergic System and Hippocampus of Status Epilepticus Rats Pretreated by Intranasal Pentoxifylline.Neuronal mechanisms of epileptogenesis.Effects of ferulic acid on oxidative stress, heat shock protein 70, connexin 43, and monoamines in the hippocampus of pentylenetetrazole-kindled rats.Repeated stimulation of dopamine D1-like receptor and hyperactivation of mTOR signaling lead to generalized seizures, altered dentate gyrus plasticity, and memory deficits.Mobile Software as a Medical Device (SaMD) for the Treatment of Epilepsy: Development of Digital Therapeutics Comprising Behavioral and Music-Based Interventions for Neurological Disorders.
P2860
Q26801864-B8C11ED2-BC7B-4D82-BDE8-F4DEC6AB0433Q27026281-105DF25E-EEC3-4041-A855-9B75E1379827Q28074736-BB128537-0C8C-4AF4-BC80-AFDB7166A621Q28256783-8DAAA8DD-BB30-49EC-B499-12B88DFDB9ABQ33882756-079265A7-0B15-4510-AC1A-8964925DD640Q36257859-FFC1A419-454F-4E29-BBC6-D5880364CEC8Q37507327-73F91FA8-F763-4443-BAD2-C77DF20CCC79Q37715741-0E3B5B10-4E66-49B1-BF2B-216622449853Q37733707-C5D75006-D87A-49C0-9E6D-936AF0E779B0Q38856602-99EEE1D1-B133-4581-993A-099361E75B4EQ41691971-7C4209E6-290F-4D94-8B49-52086C311DEEQ41895711-1A3DC205-91FB-421A-A43E-D27E216F2852Q41969625-D0ECBE87-F477-44BF-8945-5CD8029A1E51Q46450728-CCB34470-F13C-4348-9673-D2831489BBD4Q48648016-BC17E6B5-8990-4FB8-854C-84BD7F1E19AEQ55237598-31215264-5901-41E6-8712-14B7C597E2B0
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of dopamine signaling in epileptogenesis.
@en
The role of dopamine signaling in epileptogenesis.
@nl
type
label
The role of dopamine signaling in epileptogenesis.
@en
The role of dopamine signaling in epileptogenesis.
@nl
prefLabel
The role of dopamine signaling in epileptogenesis.
@en
The role of dopamine signaling in epileptogenesis.
@nl
P2860
P356
P1476
The role of dopamine signaling in epileptogenesis.
@en
P2093
Emiliana Borrelli
Yuri Bozzi
P2860
P356
10.3389/FNCEL.2013.00157
P577
2013-09-17T00:00:00Z